News - Organon
Sep 18, 2024 · Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%. October 09, 2024. Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024. September 30, 2024.
Organon & Co. (OGN) Latest Stock News & Headlines
Get the latest Organon & Co. (OGN) stock news and headlines to help you in your trading and investing decisions.
Investors Heavily Search Organon & Co. (OGN): Here is What You …
Nov 4, 2024 · For the current quarter, Organon is expected to post earnings of $0.98 per share, indicating a change of +11.4% from the year-ago quarter. The Zacks Consensus Estimate has changed +1.1% over the ...
Organon & Co. (OGN) Stock Price, News, Quote & History
Find the latest Organon & Co. (OGN) stock quote, history, news and other vital information to help you with your stock trading and investing.
Media - Organon
Review the latest news, announcements and resources from Organon.
Organon & Co. (OGN) Stock Price, Quote, News & Analysis - Seeking Alpha
A high-level overview of Organon & Co. (OGN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Organon & Co (OGN) Stock Price & News - Google Finance
Get the latest Organon & Co (OGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Merck Announces Completion of Organon & Co. Spinoff
Jun 3, 2021 · “Today marks a significant milestone for both Merck and Organon. Organon is now an independent, publicly traded company with a broad portfolio of important medicines and products, and is fully prepared to deliver sustainable growth and value,” said Rob Davis, president, Merck.
Organon Reports Results for the Fourth Quarter and Full ...
Dec 31, 2023 · Total revenue was $6.3 billion for full year 2023, an increase of 1% as-reported and an increase of 3% ex-FX, compared with the full year 2022. Women’s Health revenue increased 2% as-reported and 3% ex-FX for full year 2023 compared with 2022.
Los Angeles Capital Management LLC Buys 83,510 Shares of Organon …
1 day ago · The firm owned 259,831 shares of the company's stock after acquiring an additional 83,510 shares during the period. Los Angeles Capital Management LLC owned 0.10% of Organon & Co. worth $4,971,000 at the end of the most recent reporting period. Get Organon & Co. alerts: Merck, the Dow's hottest stock, gets set to report Q4 financials.